Gene-centric analysis identifies variants associated with interleukin-6 levels and shared pathways with other inflammation markers

Circulation: Cardiovascular Genetics

Volumn 6, Issue 2, 2013, Pages 163-170

  Shah, Tina ^a   Zabaneh, Delilah ^a   Gaunt, Tom ^b   Swerdlow, Daniel I ^a   Shah, Sonia ^a   Talmud, Philippa J ^c   Day, Ian N ^b   Whittaker, John ^d   Holmes, Michael V ^a   Sofat, Reecha ^a   Humphries, Steve E ^c   Kivimaki, Mika ^a   Kumari, Meena ^a   Hingorani, Aroon D ^a   Casas, Juan P ^a,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

C reactive protein; Genetic association study; Genetics; Interleukins

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ABO GENE; ADULT; AGED; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; BUD13 GENE; CARDIOVASCULAR DISEASE; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HLA DRB1 GENE; HUMAN; IL1RN GENE; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEZ6L GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TDRD10 GENE; TRIB3 GENE;

AGED; ALLELES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-6; RISK FACTORS;

EID: 84878046030     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.112.964254     Document Type: Article

References (53)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340: 115-126.
2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
3. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-867.
4. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169-2180.
5. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res. 2002;4(suppl 3):S233-S242.
6. Gauldie J, Northemann W, Fey GH. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. J Immunol. 1990;144:3804-3808.
7. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621-636.
8. Orr AW, Hastings NE, Blackman BR, Wamhoff BR. Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res. 2010;47:168-180.
9. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5:e78.
10. Wannamethee SG, Whincup PH, Rumley A, Lowe GD. Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost. 2007;5:1637-1643.
11. Fraser A, May M, Lowe G, Rumley A, Smith GD, Ebrahim S, et al. Interleukin-6 and incident coronary heart disease: results from the British Women's Heart and Health Study. Atherosclerosis. 2009;202:567-572.
12. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128:127-137.
13. Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GD. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 1999;104:246-257.
14. The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132-140.
15. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1-22.
16. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, Buring JE, et al. Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet. 2008;82:1185-1192.
17. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 2008;4:e1000072.
18. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA. 2009;302:37-48.
19. Okada Y, Takahashi A, Ohmiya H, Kumasaka N, Kamatani Y, Hosono N, et al. Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus. Hum Mol Genet. 2011;20:1224-1231.
20. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, et al. Metaanalysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123:731-738.
21. Wu Y, McDade TW, Kuzawa CW, Borja J, Li Y, Adair LS, et al. Genomewide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment. Inflammation. 2012;35:574-583.
22. Naitza S, Porcu E, Steri M, Taub DD, Mulas A, Xiao X, et al. A genome- wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet. 2012;8:e1002480.
23. Wörns MA, Victor A, Galle PR, Höhler T. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels-a study in twins. Genes Immun. 2006;7:600-605.
24. Smith AJ, D'Aiuto F, Palmen J, Cooper JA, Samuel J, Thompson S, et al. Association of serum interleukin-6 concentration with a functional IL6- 6331T>C polymorphism. Clin Chem. 2008;54:841-850.
25. Sanderson SC, Kumari M, Brunner EJ, Miller MA, Rumley A, Lowe GD, et al. Association between IL6 gene variants 174G>C and 572G>C and serum IL-6 levels: interactions with social position in the Whitehall II cohort. Atherosclerosis. 2009;204:459-464.
26. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE. 2008;3:e3583.
27. Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int J Epidemiol. 2005;34:251-256.
28. Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet. 1991;337:1387-1393.
29. Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, et al.; ASCOT Investigators; NORDIL Investigators; BRIGHT Consortium. Genecentric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet. 2009;85:628-642.
30. Lawlor DA, Bedford C, Taylor M, Ebrahim S. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health. 2003;57:134-140.
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
32. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007;39:906-913.
33. Akaike H. A new look at the statistical model identification. IEEE T Automat Contr. 1974;19(suppl 6):716-723.
34. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, et al. Metaanalysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123:731-738.
35. Johnson T, Gaunt TR, Newhouse SJ, Padmanabhan S, Tomaszewski M, Kumari M, et al.; Cardiogenics Consortium; Global BPgen Consortium. Blood pressure loci identified with a gene-centric array. Am J Hum Genet. 2011;89:688-700.
36. Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, Onland-Moret NC, et al.; Hugh Watkins on behalf of PROCARDIS; Meena Kumari on behalf of the Whitehall II Study and the WHII 50K Group. Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height. Am J Hum Genet. 2011;88:6-18.
37. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, Mega JL, et al.; Look AHEAD Research Group; DIAGRAM Consortium. Large-scale genecentric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012;90:410-425.
38. Danik JS, Paré G, Chasman DI, Zee RY, Kwiatkowski DJ, Parker A, et al. Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women. Circ Cardiovasc Genet. 2009;2:134-141.
39. The Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379:1214-1224.
40. IL6R Genetics Consortium Emerging Risk Factors Collaboration. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012;379:1205-1213.
41. Hamid YH, Urhammer SA, Jensen DP, Glümer C, Borch-Johnsen K, Jørgensen T, et al. Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites. Diabetes. 2004;53:3342-3345.
42. Müllberg J, Schooltink H, Stoyan T, Günther M, Graeve L, Buse G, et al. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol. 1993;23:473-480.
43. Galicia JC, Tai H, Komatsu Y, Shimada Y, Akazawa K, Yoshie H. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes Immun. 2004;5:513-516.
44. Rodríguez-Rodríguez L, Lamas JR, Varadé J, López-Romero P, Tornero- Esteban P, Abasolo L, et al. Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity. Rheumatol Int. 2011;31:409-413.
45. Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, Poli V. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene activation in the liver. Mol Cell Biol. 2001;21:1621-1632.
46. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678.
47. Smith EN, Chen W, Kähönen M, Kettunen J, Lehtimäki T, Peltonen L, et al. Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study. PLoS Genet. 2010;6:e1001094.
48. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, et al.; Wellcome Trust Case Control Consortium. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2010;30:2264-2276.
49. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40:189-197.
50. Shah S, Casas JP, Drenos F, Whittaker J, Deanfield J, Swerdlow DI, et al. Causal relevance of blood lipid fractions in the development of carotid atherosclerosis: mendelian randomization analysis. Circ Cardiovasc Genet. 2013;6:63-72.
51. CRP CHD Genetics Collaboration. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011;342:d548.
52. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al.; BIRAC Consortium; YEAR Consortium. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42:508-514.
53. Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol. 2011;38:10-20.